Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The process of virtual screening relies heavily on the databases, but it is disadvantageous to conduct virtual screening based on commercial databases with patent-protected compounds, high compound toxicity and side effects. Therefore, this paper utilizes generative recurrent neural networks (RNN) containing long short-term memory (LSTM) cells to learn the properties of drug compounds in the DrugBank, aiming to obtain a new and virtual screening compounds database with drug-like properties. Ultimately, a compounds database consisting of 26,316 compounds is obtained by this method. To evaluate the potential of this compounds database, a series of tests are performed, including chemical space, ADME properties, compound fragmentation, and synthesizability analysis. As a result, it is proved that the database is equipped with good drug-like properties and a relatively new backbone, its potential in virtual screening is further tested. Finally, a series of seedling compounds with completely new backbones are obtained through docking and binding free energy calculations. Copyright © 2024 Elsevier Inc. All rights reserved.

Citation

Wei Xia, Jin Xiao, Hengwei Bian, Jiajun Zhang, John Z H Zhang, Haiping Zhang. Deep Learning-Based construction of a Drug-Like compound database and its application in virtual screening of HsDHODH inhibitors. Methods (San Diego, Calif.). 2024 May;225:44-51

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38518843

View Full Text